Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -0.37% | 86.27 | 1.3% | $1304.25m | |
| AMGN | Amgen Inc. | 0.97% | 203.88 | 1.2% | $668.70m | |
| GILD | Gilead Sciences, Inc. | 0.77% | 69.18 | 0.9% | $573.91m | |
| LOXO | Loxo Oncology Inc | 0.11% | 233.50 | 12.7% | $483.46m | |
| BIIB | Biogen Inc. | -0.27% | 337.42 | 1.3% | $447.04m | |
| ILMN | Illumina, Inc. | 0.87% | 312.75 | 3.5% | $347.89m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.19% | 194.70 | 1.9% | $335.60m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.35% | 418.84 | 2.6% | $319.89m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.12% | 117.05 | 2.0% | $239.84m | |
| TSRO | TESARO, Inc. | 0.03% | 74.96 | 14.4% | $182.44m | |
| A | Agilent Technologies, Inc. | 2.10% | 72.31 | 1.5% | $161.80m | |
| INCY | Incyte Corporation | -0.32% | 78.42 | 2.5% | $154.32m | |
| EXAS | Exact Sciences Corporation | 4.19% | 78.80 | 25.3% | $153.44m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.22% | 122.80 | 15.4% | $139.57m | |
| LGND | Ligand Pharmaceuticals Incorporated | 6.49% | 117.90 | 23.1% | $126.24m |
Company Profile
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.